Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Blood Brain Barrier Permeability in Chronic Stroke

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mordechai Lorberboym Prof, Wolfson Medical Center
ClinicalTrials.gov Identifier:
NCT01203800
First received: September 15, 2010
Last updated: February 8, 2016
Last verified: February 2016
  Purpose
In this study the investigators intend to explore the long term significance of BBB disruption on the clinical course and the rate of significant recurrent ischemic events in patients with a chronic stroke.

Condition
A Positive or a Negative Brain SPECT

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Evaluation of Blood Brain Barrier Permeability in Chronic Stroke

Further study details as provided by Wolfson Medical Center:

Primary Outcome Measures:
  • Blood Brain Barrier permeability [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Enrollment: 30
Study Start Date: September 2009
Study Completion Date: November 2011
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Male and female patients at any age with a history of a large stroke in the territory of the middle cerebral artery, occurring 1-2 years ago or between 2-5 years ago.
Criteria

Inclusion Criteria:

  • Male and female patients at any age with a history of a large stroke in the territory of the middle cerebral artery, occurring 1-2 years ago or between 2-5 years ago.

Exclusion Criteria:

  • Lacunar strokes,
  • CNS lesions other than a stroke,
  • unable to perform the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01203800

Locations
Israel
Wolfson Medical Center
Holon, Israel, 58100
Sponsors and Collaborators
Wolfson Medical Center
  More Information

Responsible Party: Mordechai Lorberboym Prof, PI, Wolfson Medical Center
ClinicalTrials.gov Identifier: NCT01203800     History of Changes
Other Study ID Numbers: 0056-09-WOMC 
Study First Received: September 15, 2010
Last Updated: February 8, 2016
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on September 30, 2016